197 assets in Follicular Lymphoma

Cyclosporin A

Busulfanum

Irinotecan

Recombinant Human Hyaluronidase

Vincristine Sulfate

Cediranib

Cyclophosphamide

Etoposide

Rituximab

Acalabrutinib

Carboplatin

Cytarabine

Nivestim

Pegfilgrastim

Prednisone

(+)-Vincristine

Bendamustine

Prednisolone

Adriamycin

Dexasone

Vorinostat

Camustine

Lenalidomide

Fludarabine

Golcadomide

Mosunetuzumab

Obinutuzumab

Venetoclax

Tislelizumab

Zanubrutinib

Methotrexate

Anti-Cd20/Cd3 Monoclonal Antibody Regn1979

Axicabtagene Ciloleucel

Ibrutinib

Pembrolizumab

Jcar-017 Cd19-Specific Chimeric Antigen Receptor

Polatuzumab Vedotin

Brentuximab Vedotin

Epcoritamab

Human Signal Regulatory Protein Alpha (Sirp Alpha Variant V2 Extracellular D1 Domain, Sirp Alpha V2D1) Fragment 31-163, Comprising The First Two Extracellular Loops Of The D1 Domain, [N<Sup>110</Sup>>A<Sup>80</Sup>]-Variant, Anti-(Human Cd47, Integrin Associated Protein (Iap)) (1-133 In The Current Sequence) Fused Via A (G4S) 2 Peptide Linker (134-143) To Gamma 1 Heavy Chain (144-594) [Vh (Mus Musculus Ighv1-12*01 -(Ighd) -Ighj1*01, Cdr-Kabat [5.17.12](174-178.193-209.242-253)) (144-264) -Homo Sapiens Ighg1*03(Ch1 (265-362), Hinge (363-377), Ch2 S<Sup>445</Sup>>A, E<Sup>480</Sup>>A, K <Sup>481</Sup>>A (378-487), Ch3 (488-592), Chs (593-594)) (265-594)], (367-213')-Disulfide With Kappa Light Chain (1'-213') [V-Kappa (Mus Musculus Igkv4-72*01 -Igkj1*01, Cdr-Kabat [10.7.9] (24'-33'.49'-55'.88'-96')) (1'-106') -Homo Sapiens Igkc*01 (107'-213')]; Dimer (373-373'':376-376'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1, Glycoform Alfa

Melphalan

Oxaliplatin

Parsaclisib

Surovatamig

Tafasitamab

Tazemetostat

Isocyclophosphamide

Anti-Human T-Lymphocyte Immunoglobulin, Rabbit

Azacitidine

Nivolumab